{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:talicabtagene autoleucel [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT00741637: Phase 2 Interventional Completed Cholera
(2010)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT01064661: Not Applicable Interventional Completed Abdominal Pain
(2010)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT02155673: Phase 2 Interventional Completed Chronic Kidney Disease
(2014)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04470427: Phase 3 Interventional Completed SARS-CoV-2
(2020)
Source URL:
Class:
G1 SPECIFIED SUBSTANCE
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Source:
NCT04381936: Phase 3 Interventional Recruiting Severe Acute Respiratory Syndrome
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01445899: Phase 2 Interventional Completed Choroidal Neovascularization
(2012)
Source URL:
Class:
CONCEPT